Pill offers hope for skin cancer patients

A revolutionary pill for advanced skin cancer that may offer new hope to people with resistant disease is to be trialled in the UK next year.

Laboratory tests suggest that the drug, known as a panRAF inhibitor, is likely to be effective in melanoma patients no longer responding to existing treatments.

It may also help people with a strain of cancer that cannot be treated with standard drugs.